1. Home
  2. CYCC vs SMSI Comparison

CYCC vs SMSI Comparison

Compare CYCC & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • SMSI
  • Stock Information
  • Founded
  • CYCC 1992
  • SMSI 1982
  • Country
  • CYCC Malaysia
  • SMSI United States
  • Employees
  • CYCC N/A
  • SMSI N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • SMSI Computer Software: Prepackaged Software
  • Sector
  • CYCC Health Care
  • SMSI Technology
  • Exchange
  • CYCC Nasdaq
  • SMSI Nasdaq
  • Market Cap
  • CYCC 17.5M
  • SMSI 15.3M
  • IPO Year
  • CYCC N/A
  • SMSI 1995
  • Fundamental
  • Price
  • CYCC $6.37
  • SMSI $0.70
  • Analyst Decision
  • CYCC
  • SMSI Strong Buy
  • Analyst Count
  • CYCC 0
  • SMSI 1
  • Target Price
  • CYCC N/A
  • SMSI $5.00
  • AVG Volume (30 Days)
  • CYCC 82.6K
  • SMSI 111.6K
  • Earning Date
  • CYCC 11-11-2025
  • SMSI 11-12-2025
  • Dividend Yield
  • CYCC N/A
  • SMSI N/A
  • EPS Growth
  • CYCC N/A
  • SMSI N/A
  • EPS
  • CYCC N/A
  • SMSI N/A
  • Revenue
  • CYCC $10,000.00
  • SMSI $18,658,000.00
  • Revenue This Year
  • CYCC $137.21
  • SMSI $0.03
  • Revenue Next Year
  • CYCC N/A
  • SMSI $52.29
  • P/E Ratio
  • CYCC N/A
  • SMSI N/A
  • Revenue Growth
  • CYCC N/A
  • SMSI N/A
  • 52 Week Low
  • CYCC $3.08
  • SMSI $0.52
  • 52 Week High
  • CYCC $597.60
  • SMSI $1.95
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 37.28
  • SMSI 43.85
  • Support Level
  • CYCC $5.92
  • SMSI $0.71
  • Resistance Level
  • CYCC $8.82
  • SMSI $0.77
  • Average True Range (ATR)
  • CYCC 0.58
  • SMSI 0.04
  • MACD
  • CYCC -0.04
  • SMSI 0.00
  • Stochastic Oscillator
  • CYCC 15.52
  • SMSI 28.20

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.

About SMSI Smith Micro Software Inc.

Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.

Share on Social Networks: